Pick bodies in a family with presenilin-1 Alzheimer's disease

Annals of Neurology

Volumn 57, Issue 1, 2005, Pages 139-143

  Halliday, Glenda M ^a,c   Song, Yun Ju C ^a   Lepar, Gila ^a   Brooks, William S ^a   Kwok, John B ^a   Kersaitis, Cindy ^b   Gregory, Gillian ^a   Shepherd, Claire E ^a   Rahimi, Farid ^a   Schofield, Peter R ^a   Kril, Jillian J ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PRESENILIN 1; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METABOLISM; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOTTING, WESTERN; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUCINE; MALE; MEMBRANE PROTEINS; METHIONINE; MIDDLE AGED; MUTATION; NEUROFIBRILLARY TANGLES; PICK DISEASE OF THE BRAIN; POSTMORTEM CHANGES; PRESENILIN-1; SENILE PLAQUES; TAU PROTEINS;

EID: 19944428327     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20366     Document Type: Article

References (20)

1. Dermaut B, Kumar-Singh S, Engelborghs S, et al. A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques. Ann Neurol 2004;55:617-626.
2. Ikeda M, Sharma V, Sumi SM, et al. The clinical phenotype of two missense mutations in the presenilin 1 gene in Japanese patients. Ann Neurol 1996;40:912-917.
3. Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
4. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
5. Stanford PM, Shepherd CE, Halliday GM, et al. Mutations in the tau gene that cause an increase in 3 repeat tau and fronto-temporal dementia. Brain 2003;126:814-826.
6. Barber R, Snowden JS, Craufurd D. Frontotemporal dementia and Alzheimer's disease: retrospective differentiation using information from informants. J Neurol Neurosurg Psychiatry 1995;59:61-70.
7. Broe M, Hodges JR, Schofield E, et al. Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 2003;60:1005-1011.
8. Goedert M, Spillantini MG, Cairns NJ, Crowther RA. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 1992;8:159-168.
9. Smith DA, Lantos PL. A case of combined Pick's disease and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1983;46: 675-677.
10. Pogacar S, Rubio A. Morphological features of Pick's and atypical Alzheimer's disease in Down's syndrome. Acta Neuropathol 1982;58:249-254.
11. Hof PR, Bouras C, Perl DP, Morrison JH. Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease. Acta Neuropathol 1994;87:115-124.
12. Dickson DW, Yen SH, Horoupian DS. Pick body-like inclusions in the dentate fascia of the hippocampus in Alzheimer's disease. Acta Neuropathol 1986;71:38-45.
13. Armstrong RA, Cairns NJ, Lantos PL. Laminar distribution of Pick bodies, Pick cells and Alzheimer disease pathology in the frontal and temporal cortex in Pick's disease. Neuropathol Appl Neurobiol 1999;25:266-271.
14. Haass C, De Strooper B. The presenilins in Alzheimer's disease-proteolysis holds the key. Science 1999;286:916-919.
15. Schwab C, McGeer PL, Aβ42-carboxy-terminal-like immunoreactivity is associated with intracellular neurofibrillary tangles and Pick bodies. Exp Neurol 2000;161:527-534.
16. Sergeant N, David JP, Champain D, et al. Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated wich tau pathology stages, in Alzheimer's disease. J Neurochem 2002;81:663-672.
17. Shepherd CS, Gregory GC, Vickers JC, et al. Positional effects of presenilin-1 muations on tau phosphorylation in cortical plaques. Neurobiol Dis 2004;15:115-119.
18. Boutajangout A, Auihelet M, Blanchard V, et al. Characterisation of cytoskeletal abnormalities in mice transgenic for wildtype human tau and familial Alzheimer's disease mutants of APP and presenilin-1. Neurobiol Dis 2004;15:47-60.
19. Feng R, Wang H, Wang J, et al. Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2. Proc Natl Acad Sci USA 2004;101:8162-8167.
20. Lee VM-Y, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 2001;24:1121-1159.